Current Vascular Pharmacology
Title:Meet Our Co-Editor
Volume: 15 Issue: 2
Author(s): Anthony S. Wierzbicki
Affiliation:
Export Options
About this article
Cite this article as:
Wierzbicki S. Anthony, Meet Our Co-Editor, Current Vascular Pharmacology 2017; 15 (2) . https://dx.doi.org/10.2174/157016111502170109145528
DOI https://dx.doi.org/10.2174/157016111502170109145528 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System
Inhibition: Implications for Practice
Current Hypertension Reviews The Etiology of Hypertension in the Metabolic Syndrome Part Three: The Regulation and Dysregulation of Blood Pressure
Current Vascular Pharmacology Relationship between Diabetes Mellitus and Coronary Heart Disease
Current Diabetes Reviews MicroRNAs in Cardiovascular Therapeutics
Current Topics in Medicinal Chemistry Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?
Current Cardiology Reviews Novel Therapeutic Strategies Targeting Vascular Redox in Human Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Current Vascular Pharmacology Myocardial Contrast Echocardiography: Role in Clinical Cardiology
Current Vascular Pharmacology Synthesis of 1,2,4-triazole Derivatives: Binding Properties on Endothelin Receptors
Medicinal Chemistry Role of the Akt Pathway in Prostate Cancer
Current Cancer Drug Targets Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Natural Plants with Antiepileptic Activity-The Present and Future Perspectives
The Natural Products Journal Renovascular Hypertension: Lesion Detection, Patient Selection, Treatment Options and Results
Current Hypertension Reviews Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence
Current Cardiology Reviews Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial
Current Alzheimer Research Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Current Drug Targets Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs The Epidemiology of Cardiovascular Disease in Adults with Type 1 Diabetes
Current Diabetes Reviews Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued)